146 related articles for article (PubMed ID: 1383625)
41. Therapeutic implications of diazepam in patients with elevated left ventricular filling pressure.
Côte P; Campeau L; Bourassa MG
Am Heart J; 1976 Jun; 91(6):747-51. PubMed ID: 1274825
[TBL] [Abstract][Full Text] [Related]
42. Amiodarone. Haemodynamic profile during intravenous administration and effect on pacing-induced ischaemia in man.
Remme WJ; van Hoogenhuyze DC; Kruyssen DA; Krauss XH; Storm CJ
Drugs; 1985 Mar; 29 Suppl 3():11-22. PubMed ID: 3996243
[TBL] [Abstract][Full Text] [Related]
43. Effects of verapamil on myocardial performance in coronary disease.
Ferlinz J; Easthope JL; Aronow WS
Circulation; 1979 Feb; 59(2):313-9. PubMed ID: 365390
[TBL] [Abstract][Full Text] [Related]
44. Acute and chronic effects of propionyl-L-carnitine on the hemodynamics, exercise capacity, and hormones in patients with congestive heart failure.
Anand I; Chandrashekhan Y; De Giuli F; Pasini E; Mazzoletti A; Confortini R; Ferrari R
Cardiovasc Drugs Ther; 1998 Jul; 12(3):291-9. PubMed ID: 9784909
[TBL] [Abstract][Full Text] [Related]
45. Hemodynamic and cardiac metabolic effects of inotropic stimulation with dobutamine in patients with coronary artery disease.
Kupper W; Waller D; Hanrath P; Bleifeld W
Eur Heart J; 1982 Feb; 3(1):29-34. PubMed ID: 7075609
[No Abstract] [Full Text] [Related]
46. [Effect of digoxin on coronary circulation and myocardial O2-consumption in patients with angina pectoris].
Kötter V; Schüren KP; Schröder R
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1644-7. PubMed ID: 611900
[No Abstract] [Full Text] [Related]
47. Systemic and cardiac neuroendocrine activation and severity of myocardial ischemia in humans.
Remme WJ; Kruyssen DA; Look MP; Bootsma M; de Leeuw PW
J Am Coll Cardiol; 1994 Jan; 23(1):82-91. PubMed ID: 8277100
[TBL] [Abstract][Full Text] [Related]
48. Effects of L-propionylcarnitine on mechanical recovery during reflow in intact hearts.
Liedtke AJ; DeMaison L; Nellis SH
Am J Physiol; 1988 Jul; 255(1 Pt 2):H169-76. PubMed ID: 3394817
[TBL] [Abstract][Full Text] [Related]
49. Hemodynamic assessment of intravenous bepridil administration in ischemic heart disease.
Tamari I; Borer JS; Moses JW; Goldberg HL; Fisher J; Wallis JB; Halle A
Am J Cardiol; 1985 Mar; 55(7):25C-29C. PubMed ID: 3872054
[TBL] [Abstract][Full Text] [Related]
50. Acute haemodynamic effects of cromakalim in patients with angina pectoris.
Thomas P; Dixon MS; Winterton SJ; Sheridan DJ
Br J Clin Pharmacol; 1990 Mar; 29(3):325-31. PubMed ID: 2310656
[TBL] [Abstract][Full Text] [Related]
51. Prolonged propionyl-L-carnitine pre-treatment of rabbit: biochemical, hemodynamic and electrophysiological effects on myocardium.
Ferrari R; Di Lisa F; de Jong JW; Ceconi C; Pasini E; Barbato R; Menabò R; Barbieri M; Cerbai E; Mugelli A
J Mol Cell Cardiol; 1992 Mar; 24(3):219-32. PubMed ID: 1625347
[TBL] [Abstract][Full Text] [Related]
52. Anti-arrhythmic effects of (-)-carnitine chloride and its acetyl analogue on canine late ventricular arrhythmia induced by ligation of the coronary artery as related to improvement of mitochondrial function.
Imai S; Matsui K; Nakazawa M; Takatsuka N; Takeda K; Tamatsu H
Br J Pharmacol; 1984 Jun; 82(2):533-42. PubMed ID: 6733367
[TBL] [Abstract][Full Text] [Related]
53. Metabolic and hemodynamic effects of intravenous glutamate infusion early after coronary operations.
Svedjeholm R; Vanhanen I; Håkanson E; Joachimsson PO; Jorfeldt L; Nilsson L
J Thorac Cardiovasc Surg; 1996 Dec; 112(6):1468-77. PubMed ID: 8975838
[TBL] [Abstract][Full Text] [Related]
54. L-propionylcarnitine effects on cardiac carnitine content and function in secondary carnitine deficiency.
Broderick TL; DiDomenico D; Shug AL; Paulson DJ
Can J Physiol Pharmacol; 1995 Apr; 73(4):509-14. PubMed ID: 7671193
[TBL] [Abstract][Full Text] [Related]
55. Acute myocardial ischaemia induces cardiac carnitine release in man.
Bartels GL; Remme WJ; Scholte HR
Eur Heart J; 1997 Jan; 18(1):84-90. PubMed ID: 9049519
[TBL] [Abstract][Full Text] [Related]
56. Systemic vasodilatation following diazepam after combined sympathetic and parasympathetic blockade in patients with coronary heart disease.
Côté P; Noble J; Bourassa MG
Cathet Cardiovasc Diagn; 1976; 2(4):369-80. PubMed ID: 1000625
[TBL] [Abstract][Full Text] [Related]
57. Haemodynamic and metabolic effects of the antiarrhythmic drug melperone during acute left ventricular failure in dogs.
Smiseth OA; Platou ES; Refsum H; Mjøs OD
Cardiovasc Res; 1981 Dec; 15(12):724-30. PubMed ID: 7326689
[TBL] [Abstract][Full Text] [Related]
58. Effect of L-carnitine on cardiac hemodynamics.
Suzuki Y; Kamikawa T; Yamazaki N
Jpn Heart J; 1981 Mar; 22(2):219-25. PubMed ID: 7230522
[TBL] [Abstract][Full Text] [Related]
59. Hemodynamic effects and tolerability of intravenous amiodarone in patients with impaired left ventricular function.
Remme WJ; Kruyssen HA; Look MP; van Hoogenhuyze DC; Krauss XH
Am Heart J; 1991 Jul; 122(1 Pt 1):96-103. PubMed ID: 2063768
[TBL] [Abstract][Full Text] [Related]
60. Left ventricular wall motion response to intravenous propranolol.
Shubrooks SJ; Zir LM; Dinsmore RE; Harthorne JW
Circulation; 1975 Jul; 52(1):124-9. PubMed ID: 1132115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
